Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement GOODO Q1 2026 Earnings Strong EPS Surprise of 5686 Boosts Investor Confidence MaxCyte MXCT Q1 2026 Earnings EPS Surprises Positively on LowerThanExpected Loss Revenue Not Disclosed Corvex Inc MOVE Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside BMY Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline and Pipeline Advances GAIA Q1 2026 Earnings Loss Narrowly Misses Estimates Shares Rise on Strategic Progress